Anovulation Created 2026-10-31 Updated 2026-11-05
Corpus luteum 2026-11-05
The corpus luteum is a temporary endocrine structure formed from the ovarian follicle after ovulation. Its luteinized cells produce substantial progesterone, helping maintain the secretory state of the endometrium. Without sustained hormonal support it regresses; in early pregnancy, human chorionic gonadotropin helps preserve its steroid production.[ref]
Anatomy and Physiology 2e by J. Gordon Betts and others. Section 27.2, ovulation, corpus luteum and ovarian-cycle hormone changes
It illustrates that an endocrine gland need not be a permanently separate organ. A local tissue is reorganized into a hormone-secreting structure and later changes again. A measured progesterone concentration reflects both this production and removal from the blood, so it is not a direct count of luteal cells.
Gestation Created 2026-10-31 Updated 2026-11-05
Gestation is the period during which an embryo or fetus develops within a maternal body before birth. In placental mammals, the placenta supports exchange between maternal and fetal circulations; gestation therefore involves coordinated maternal physiology as well as growth of the offspring.
Dating conventions matter. Human clinical gestational age is ordinarily counted from the start of the last menstrual cycle, rather than directly from fertilization, so it is commonly about two weeks greater than age since fertilization in an idealized 28-day cycle. Variable ovulation means that this offset is not an exact biological constant.[ref]
J. D. Hoff 2026-11-05
J. D. Hoff is an author of the 1983 study Hormonal dynamics at midcycle: a reevaluation by J. D. Hoff and others, which examined how hormones from the ovary and pituitary gland change around ovulation. Its contribution was a time-resolved comparison: samples from five participants were taken at two-hour intervals over five days, allowing changes in estradiol, progesterone, luteinizing hormone and follicle-stimulating hormone to be aligned around the onset of the luteinizing hormone surge.[ref]
Hormonal dynamics at midcycle: a reevaluation by J. D. Hoff and others. abstract, study design and timing reference
That alignment exposed relationships which a single measurement could miss: the surge began abruptly near peak estradiol, while the rise in progesterone had already begun. The experiment supplied a temporal picture of the hypothalamic–pituitary–ovarian axis; temporal association by itself does not prove which change caused another. The cited paper identifies Hoff by initials, which are retained here.
Luteinising hormone 2026-11-05
Luteinising hormone is a gonadotropin released by the anterior pituitary under hypothalamic control. It acts on the gonads: in testes it stimulates steroid production by Leydig cells, while in an ovarian cycle its surge helps trigger ovulation and the transition to a corpus luteum.[ref]
Biology 2e by Mary Ann Clark and others. Section 43.4, hormonal control of the reproductive systems
The signal is dynamic. A sustained low concentration and a brief surge need not have the same physiological meaning, and a sparse sampling schedule can miss a peak. The same hormone also acts in different cellular contexts, illustrating that a hormone's identity alone does not determine one universal response. Receptor expression, developmental state and the other gonadal signals contribute to the outcome.
Luteinization 2026-11-05
Luteinization is the differentiation and reorganization of follicular cells into the steroid-secreting cells of the corpus luteum. Granulosa cells and theca cells change their endocrine activity, with increased capacity for progesterone production. In the normal ovarian cycle, the luteinizing hormone surge coordinates this process with ovulation. Release of the oocyte and transformation of the remaining follicular tissue are nevertheless distinct events.[ref]
Anatomy and Physiology 2e by J. Gordon Betts and others. Section27.2: ovulation,corpus-luteum formation and steroid secretion
A functional experiment examines what the differentiated cells actually make. In a 1991 study, human luteinized granulosa cells were cultured for 48 hours with or without human chorionic gonadotropin or follicle-stimulating hormone. The investigators measured several steroids and assayed aromatase activity separately. Progesterone production was prominent and responsive to stimulation, demonstrating endocrine activity in the luteinized preparation.[ref]
This motivates a useful distinction between cell state and one of its outputs. Increased progesterone is evidence of altered steroid production, but one concentration measurement does not by itself prove that a whole follicle has ruptured, that an oocyte was released, or that every structural step of luteinization occurred. Comparing histology with biochemical measurements makes the interpretation more precise.
Luteinizing hormone 2026-11-05
Luteinizing hormone (LH) is a glycoprotein gonadotropin released by gonadotrophs in the anterior pituitary under control of gonadotropin-releasing hormone. It participates in ovulation and formation of the corpus luteum, and promotes testosterone production in the testis. The hormone's output is regulated within interacting pituitary and gonadal feedback pathways.[ref]
Anatomy and Physiology 2e by J. Gordon Betts and others. Section 17.3: Luteinizing Hormone and the pituitary hormone summary
The shape of a LH surge can be investigated by measuring several signals through time. In 1983, J. D. Hoff and colleagues studied five women with hormone measurements every two hours for five consecutive days around midcycle. They compared estradiol, progesterone and gonadotropin trajectories, finding an abrupt onset of the LH and follicle-stimulating hormone surges in temporal association with the estradiol peak.[ref]
Hormonal dynamics at midcycle: a reevaluation by J. D. Hoff and others. Abstract: sampling schedule, surge onset and the associated ovarian hormone changes
The report included a doubling of LH within a two-hour interval at surge onset. Such a change illustrates why sampling frequency matters: coarse measurements can blur an abrupt transition or shift the apparent ordering of events. The study describes a measured cohort pattern; it does not turn one isolated hormone measurement into a complete account of the cycle.
The relation to GnRH can also be probed by paired portal and peripheral blood plasma measurements. The hypophyseal portal system makes those two locations physiologically different: one carries the hypothalamic input, while the other records the pituitary's released output.
Menopause Created 2026-10-31 Updated 2026-11-05
Menopause marks the end of menstrual cycling associated with loss of ovarian reproductive activity. Natural human menopause is identified retrospectively after twelve months without menstruation, when another cause does not account for the absence. The preceding transition can include irregular cycles and changing ovarian hormone production.[ref]
Menopause by the National Institutes of Health. Overview; Recognizing Menopause
A single hormone measurement cannot reliably locate every individual within that transition because concentrations fluctuate. Irregular menstruation during the transition does not itself establish that ovulation has permanently stopped.[ref]
Menopause by the National Institutes of Health. Overview; Recognizing Menopause
Menstrual cycle 2026-11-05
The menstrual cycle coordinates recurring ovarian and uterine changes through hormonal feedback. Cycle day one is conventionally the first day of menstrual bleeding. The ovarian sequence includes follicular development, ovulation and a luteal phase; the uterine lining undergoes shedding, proliferation and secretory changes in response to the changing signals.[ref]
Biology 2e by Mary Ann Clark and others. Section 43.4, ovarian and uterine cycles and their hormonal coordination
These are linked sequences, not identical names for one anatomical event. Follicular development concerns the ovary, while endometrial proliferation concerns the uterus. Luteinising hormone, ovarian estrogens and progesterone couple the two. A twenty-eight-day schematic is a teaching example rather than a rule that every cycle has that duration or ovulates on day fourteen. Comparing observations requires specifying the event or phase used to align the records.
Menstruation Created 2026-10-31 Updated 2026-11-05
Menstruation is cyclic shedding of blood and endometrium tissue through the vagina. During a human menstrual cycle, ovarian hormones regulate the growth and maintenance of the endometrium; a decline in hormonal support is followed by shedding when a pregnancy has not become established.[ref]
The first day of bleeding conventionally starts a new menstrual cycle. Menstruation describes a uterine event, whereas ovulation describes release of an oocyte from an ovary; treating the two as interchangeable obscures how the hypothalamic–pituitary–ovarian axis coordinates different organs.
Ovarian follicle 2026-11-05
An ovarian follicle is an oocyte together with the surrounding supporting cells in an ovary. Follicle development changes both the oocyte's environment and the organization of the surrounding tissue. Growing follicles acquire granulosa and theca cell layers; later stages can develop a fluid-filled cavity.[ref]
Anatomy and Physiology 2e by J. Gordon Betts and others. Section 27.2, ovarian follicles and follicular development
A follicle is thus more than an egg under another name. Its supporting cells participate in signaling and steroid production, while interactions with the oocyte support development. Following ovulation, remaining follicular tissue can become the corpus luteum. The oocyte's fate and the supporting tissue's fate therefore diverge during the same reproductive event.
Ovary (anatomy) 2026-11-05
An ovary is a female gonad supporting oocyte development and reproductive hormone production. In mammalian anatomy, an ovarian follicle combines the developing germ cell with supporting somatic cells; ovulation releases the oocyte from this structure. The animal organ is distinct from an ovary in a flower.
Ovulation Created 2026-10-31 Updated 2026-11-05
Ovulation is release of an oocyte from an ovarian follicle in the ovary. In the human menstrual cycle, rising luteinising hormone precedes this event; the released oocyte can subsequently encounter sperm in a fallopian tube. Ovulation and fertilization are separate events: releasing an oocyte does not establish a pregnancy.[ref]
Ovulatory dysfunction Created 2026-10-31 Updated 2026-11-05
Resuscitate significant haemorrhage while identifying its cause; pregnancy, timing in relation to birth, and the condition of the uterus determine the definitive treatment. A vaginal loss need not originate in the uterus, and the visible volume may underestimate concealed bleeding. Assess consciousness, pulse, blood pressure and ongoing loss; serious bleeding calls for urgent obstetric or gynaecological help, intravenous access, blood sampling and access to blood transfusion. Investigations must not delay control of a life-threatening source.
Outside pregnancy, distinguish excessive menstrual bleeding from irregular, postcoital or postmenopausal bleeding. Causes include uterine fibroids, endometrial polyps, disturbed ovulation, coagulopathy and cancer. A speculum examination may reveal a cervical or vaginal source. History, examination, blood count, and appropriately selected ultrasonography, hysteroscopy or tissue sampling establish the cause. Current treatment for heavy menstrual bleeding may use tranexamic acid or hormonal treatment where suitable; removal of a polyp or treatment of a uterine fibroid addresses a structural cause. Suspected cancer needs a diagnostic and specialist pathway, rather than repeated empirical suppression of bleeding.[ref]
Heavy menstrual bleeding by NICE. NG88, investigation according to history and examination, and cause-directed treatment
In early pregnancy, consider threatened or established miscarriage and retained pregnancy tissue. Establish the location and viability of the pregnancy with ultrasonography and, where appropriate, serial human chorionic gonadotropin measurements. Stable cases permit a choice among expectant, medical or surgical management according to the diagnosis and circumstances; heavy ongoing bleeding or instability changes the urgency. An ectopic pregnancy may cause vaginal bleeding together with dangerous internal haemorrhage, even though the bleeding pregnancy is outside the uterus. Pain, collapse or instability therefore demands urgent assessment rather than an assumption that all bleeding represents a harmless menstrual or uterine event.[ref]
Ectopic pregnancy and miscarriage by NICE. NG126, §§1.3–1.7: emergency assessment, diagnosis and management
Later pregnancy requires distinction between placenta praevia, placental abruption and other genital-tract sources. Placenta praevia may cause heavy painless bleeding; placental abruption may involve pain, a tense uterus and concealed loss. Stabilise the mother, assess the fetus and locate the placenta by ultrasonography. Avoid a digital examination that could disturb a covering placenta before placenta praevia has been excluded. The timing and route of birth depend on severity, placental position, gestation and maternal and fetal condition. A placenta covering the cervical opening usually requires Caesarean section; the diagnosis is not an instruction to apply a vaginal plug and wait through major continuing loss.[ref]
Placenta praevia, placenta accreta and vasa praevia by RCOG. Bleeding, ultrasound assessment and planning birth
[ref]Antepartum haemorrhage by RCOG. Green-top Guideline 63, §7.3: digital examination precaution
During and after birth, organise postpartum haemorrhage causes as poor uterine contraction, retained tissue, genital-tract trauma and defective clotting. A uterine rupture is a surgical emergency; a contracting uterus does not exclude a traumatic source. For uterine atony, uterine massage and a suitable uterotonic accompany resuscitation; emptying a distended urinary bladder may help contraction. Examine for tears and repair them; deal with retained placental tissue with skilled obstetric care, and do not forcibly detach an abnormally adherent placenta. Correct relevant coagulopathy and use blood products as indicated. Current early treatment includes tranexamic acid within the recommended interval. Continuing bleeding may require balloon tamponade or surgery; a uterine inversion requires urgent skilled replacement and resuscitation, not treatment as simple atony. Delayed bleeding after birth suggests retained tissue or infection and requires renewed assessment.[ref]
Consolidated guidelines for the prevention, diagnosis and treatment of postpartum haemorrhage by the World Health Organization (2025). First-response treatment bundle and cause-directed management of refractory bleeding
An 1864 practitioner could recognise miscarriage, abnormal placental attachment or separation, retained placenta, atony and traumatic bleeding, and could attempt pressure, manual measures and delivery appropriate to the cause. Cold applications and vaginal plugging appeared in period practice, but were not interchangeable cures. Contemporary obstetric discussion already distinguished several mechanisms of bleeding.[ref]
Quarterly Report on Midwifery (April 1864). pp. 549–556: uterine disease, pregnancy and obstetric complications
In particular, a uterotonic cannot repair a tear, and obstructing the outflow does not establish that internal haemorrhage has ceased. The modern diagnostic and resuscitative measures above explain why treatment must follow the mechanism rather than the symptom alone. Progesterone 2026-11-05
Progesterone is a steroid hormone produced prominently by the corpus luteum after ovulation and by the placenta during pregnancy. It helps transform and maintain the endometrium in a state that supports implantation and subsequent pregnancy. Its withdrawal, alongside other hormonal changes, contributes to menstruation when pregnancy is not established.[ref]
Biology 2e by Mary Ann Clark and others. Section 43.4, ovarian and uterine hormonal control
Like other steroid signals, progesterone can act through a nuclear receptor to change gene expression. Its effect is therefore not merely the presence of a substance in blood: transport, receptor availability and tissue state shape the response. A post-ovulatory progesterone rise and an estrogen-driven proliferative phase describe different parts of the coordinated ovarian and uterine cycle.